[1]
Agrawal, A. 2025. Pharmacological Prevention of Severe Respiratory Syncytial Virus Infection in High-Risk Infants and Children: Maternal Immunization and Long-Acting Monoclonal Antibodies. Indian Journal of Pharmacy & Drug Studies. 4, 3 (Sep. 2025), 95–101.